LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 124 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $458,709 | -13.1% | 273,041 | +24.1% | 0.00% | – |
| Q1 2024 | $527,858 | +40.6% | 219,941 | -10.3% | 0.00% | – |
| Q4 2023 | $375,311 | +40.4% | 245,301 | 0.0% | 0.00% | – |
| Q3 2023 | $267,378 | -48.6% | 245,301 | +8.0% | 0.00% | – |
| Q2 2023 | $520,084 | +129.1% | 227,111 | +143.1% | 0.00% | – |
| Q1 2023 | $226,989 | +32.3% | 93,411 | +4.0% | 0.00% | – |
| Q4 2022 | $171,539 | -15.9% | 89,811 | +5.6% | 0.00% | – |
| Q3 2022 | $204,000 | +94.3% | 85,011 | +50.2% | 0.00% | – |
| Q2 2022 | $105,000 | 0.0% | 56,611 | +12.3% | 0.00% | – |
| Q1 2022 | $105,000 | -46.7% | 50,411 | +0.6% | 0.00% | – |
| Q4 2021 | $197,000 | -18.3% | 50,111 | 0.0% | 0.00% | – |
| Q3 2021 | $241,000 | -6.6% | 50,111 | -10.7% | 0.00% | – |
| Q2 2021 | $258,000 | -0.4% | 56,111 | +27.2% | 0.00% | – |
| Q1 2021 | $259,000 | +29.5% | 44,111 | -24.7% | 0.00% | – |
| Q4 2020 | $200,000 | +26.6% | 58,611 | -46.7% | 0.00% | – |
| Q3 2020 | $158,000 | -56.5% | 110,053 | -39.4% | 0.00% | – |
| Q2 2020 | $363,000 | +31.0% | 181,753 | +28.2% | 0.00% | – |
| Q1 2020 | $277,000 | -32.3% | 141,803 | +44.0% | 0.00% | – |
| Q4 2019 | $409,000 | +38.2% | 98,503 | 0.0% | 0.00% | – |
| Q3 2019 | $296,000 | -52.3% | 98,503 | 0.0% | 0.00% | – |
| Q2 2019 | $620,000 | +39.0% | 98,503 | +22.7% | 0.00% | – |
| Q1 2019 | $446,000 | -24.8% | 80,303 | -10.1% | 0.00% | – |
| Q4 2018 | $593,000 | -33.2% | 89,303 | +7.3% | 0.00% | -100.0% |
| Q3 2018 | $888,000 | -11.3% | 83,203 | -0.2% | 0.00% | 0.0% |
| Q2 2018 | $1,001,000 | +56.9% | 83,382 | +11.9% | 0.00% | – |
| Q1 2018 | $638,000 | -13.3% | 74,482 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $736,000 | -67.1% | 74,482 | -59.0% | 0.00% | -50.0% |
| Q3 2017 | $2,234,000 | +66.1% | 181,782 | +122.3% | 0.00% | +100.0% |
| Q2 2017 | $1,345,000 | -50.5% | 81,782 | -56.8% | 0.00% | -50.0% |
| Q1 2017 | $2,717,000 | +3.1% | 189,492 | -0.6% | 0.00% | 0.0% |
| Q4 2016 | $2,636,000 | -29.0% | 190,572 | -7.3% | 0.00% | -33.3% |
| Q3 2016 | $3,714,000 | +80.6% | 205,542 | +43.5% | 0.00% | +50.0% |
| Q2 2016 | $2,056,000 | +170.2% | 143,260 | +125.0% | 0.00% | +100.0% |
| Q1 2016 | $761,000 | -11.2% | 63,680 | -1.0% | 0.00% | 0.0% |
| Q4 2015 | $857,000 | +4.9% | 64,351 | -15.4% | 0.00% | 0.0% |
| Q3 2015 | $817,000 | +25.3% | 76,101 | -6.0% | 0.00% | 0.0% |
| Q2 2015 | $652,000 | – | 80,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 175,099,384 | $294,166,966 | 7.50% |
| Opaleye Management Inc. | 1,875,000 | $3,150,000 | 0.72% |
| BRAIDWELL LP | 8,294,950 | $13,935,516 | 0.44% |
| NEA Management Company, LLC | 2,382,286 | $4,002,240 | 0.30% |
| Nantahala Capital Management | 2,304,150 | $3,870,972 | 0.23% |
| Orbimed Advisors | 5,846,100 | $9,821,448 | 0.19% |
| Virtus ETF Advisers LLC | 179,972 | $302,353 | 0.15% |
| Altium Capital Management LP | 121,986 | $204,936 | 0.08% |
| Hennion & Walsh Asset Management, Inc. | 542,899 | $912,070 | 0.05% |
| PINNACLE ASSOCIATES LTD | 1,715,831 | $2,882,596 | 0.04% |